Cargando...
2019 novel coronavirus disease (COVID‐19) in patients with inflammatory bowel diseases
BACKGROUND: Data on patients with inflammatory bowel diseases (IBD) who have had 2019 novel coronavirus (SARS‐CoV‐2) disease (COVID‐19) are needed. AIMS: To report the clinical characteristics, including gastrointestinal symptoms, of COVID‐19 in IBD patients, and to assess the risk of COVID‐19 in IB...
Guardado en:
| Publicado en: | Aliment Pharmacol Ther |
|---|---|
| Autores principales: | , , , , , |
| Formato: | Artigo |
| Lenguaje: | Inglês |
| Publicado: |
John Wiley and Sons Inc.
2020
|
| Materias: | |
| Acceso en línea: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7267496/ https://ncbi.nlm.nih.gov/pubmed/32359205 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/apt.15804 |
| Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|